By working together to address this grave threat, we can uphold the integrity of the pharmaceutical industry and protect the health and safety of individuals ... Mar 07
India’s first indigenously developed human papillomavirus (HPV) vaccine will be soon administered to women in near future. The research and development related to vaccines ... Sep 02
A cancer patient has new hope for a cancer cure now. Let us look into details to beat cancer with the new drug Dostarlimab. ... Jun 09
Latest pharma news update... Aug 02
GSK plc today announced positive headline results from five studies of the Phase 3 ASCEND programme, for patients with anaemia due to chronic kidney disease (... Jul 17
Halozyme’s drug delivery technology provides the opportunity to administer large volume subcutaneous injections that may enable dosing intervals of every three months and up ... Jun 22
With this collaboration GSK is uniquely positioned with access to antibodies that synergistically target all three known CD226 checkpoints - TIGIT, CD96 and PVRIG.... Jun 14
GSK's Covid product could be soon in the market after the emergency medical application review... May 11
GSK gets FDA nod for Jemperli indicated for endometrial cancer... Apr 26
The FDA EUA submission is based on an interim analysis of efficacy and safety data from the Phase 3 COMET-ICE ... Mar 27
The agreement is for the advancement of multiple pre-phase 2 programs... Mar 22
It could be of use at a later stage all the more if the fight against variants was to continue, said the CEO ... Feb 15
GSK plc announced updated data from GARNET cohort F evaluating dostarlimab in mismatch repair-deficient non-endometrial advanced solid cancers being presented today at the ... Jan 18
Tivicay contains dolutegravir, an integrase strand transfer inhibitor for use in combination with other antiretroviral agents for the treatment of HIV... Jan 15
... Jan 13
Vir Biotechnology, Inc. and GlaxoSmithKline plc today announced an agreement with the U.K.-based AGILE initiative to evaluate VIR-7832 in patients with mild ... Jan 12
GSK licenses global rights to a portfolio of GPR35 agonists designed by Sosei Heptares using its StaR technology and structure-based drug design platform... Dec 22
This authorization represents the first time people living with HIV in Europe may be able to receive a long-acting injectable treatment that removes the ... Dec 21
ACTIV-3 is an NIH-led public-private partnership designed to accelerate the development of the most promising treatments and vaccine candidates for COVID-19.... Dec 18
BENLYSTA is the first medicine approved to treat systemic lupus and adults with active lupus nephritis, an important treatment advance for patients with this incurable ... Dec 18
Fostemsavir addresses a critical unmet need in HIV care for those with little to no treatment options left.... Dec 11
The BMJ’s attempts to discover more have been thwarted ... Dec 11
If approved, Nucala would be the only treatment approved in the US for use in four eosinophil-driven diseases. ... Dec 08
Currently no vaccine is available for respiratory syncytial virus... Nov 23
-Advertisements-
Wednesday, April 24, 2024
